The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Why the latest brenetafusp data matters for Immunocore Holdings (NasdaqGS:IMCR) Immunocore Holdings (NasdaqGS:IMCR) drew ...

Immunocore Holdings (IMCR) has drawn investor attention after recent share performance data showed the stock down about 3% over the past month and roughly 4% over the past 3 months. See our latest ...

The latest price target for Immunocore Holdings (NASDAQ:IMCR) was reported by HC Wainwright & Co. on April 20, 2026. The analyst firm set a price target for $100.00 expecting IMCR to rise to within 12 ...

Immunocore Hldgs (NASDAQ:IMCR) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. Summarizing their recent assessments, the table below ...

Immunocore Hldgs (NASDAQ:IMCR) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the ...

DUBLIN (Reuters) - Immunocore completed Europe's largest ever financing round by a private life sciences company on Thursday, raising $320 million from investors including Eli Lilly & Co (LLY.N), ...

Immunocore, the UK biotech leading in the nascent field of TCR immunotherapy, has appointed Andrew Hotchkiss as its new Chief Commercial Officer. Hotchkiss joins from Lilly, where he has held numerous ...

GlaxoSmithKline has selected a third target in its collaboration with Oxford, UK-based Immunocore to discover multiple novel targets in cancer not addressable with antibody-based technologies.